ストックスクリーナーアプリを入手
1.11
3.74%
0.04
アフターアワーズ：
1.09
-0.02
-1.80%
前日終値:
$1.07
開ける：
$1.08
24時間の取引高:
1.68M
Relative Volume:
2.05
時価総額：
$211.74M
収益：
$4.71M
当期純損益:
$-58.01M
株価収益率:
-1.3481
EPS:
-0.8234
ネットキャッシュフロー:
$-46.68M
1週間 パフォーマンス:
+17.21%
1か月 パフォーマンス:
+3.74%
6か月 パフォーマンス:
+3.74%
1年 パフォーマンス:
-30.19%
1日の値動き範囲:
$1.065
$1.12
1週間の範囲:
$0.90
$1.12
52週間の値動き範囲:
$0.90
$1.70
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.11 | 204.11M | 4.71M | -58.01M | -46.68M | -0.8234 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-27 | 開始されました | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 開始されました | BTIG Research | Buy |
| 2021-11-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 開始されました | Needham | Buy |
Lucid Diagnostics Inc (LUCD) 最新ニュース
LUCD News | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill
Director buys 245K Lucid Diagnostics (NASDAQ: LUCD) shares in market - Stock Titan
Lucid Diagnostics Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LUCD) 2026-05-17 - Seeking Alpha
Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... By GuruFocus - Investing.com Canada
Upcoming Events - FinancialContent
Maxim Group Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Cuts Target Price to $2 - Moomoo
BTIG Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $2.5 - Moomoo
PAVmed (PAVM) Q1 2026 Earnings Transcript - AOL.com
PAVmed (PAVM) Q4 2025 Earnings Transcript - The Globe and Mail
PAVmed Reports Q1 2026 Financial Results, Highlights Progress in Veris Health FDA Submission and Lucid Diagnostics Commercial Expansion - Minichart
Earnings Call Summary | Lucid Diagnostics(LUCD.US) Q1 2026 Earnings Conference - 富途牛牛
PAVmed Reports Wider-than-Expected Q1 2026 Loss - AlphaStreet
Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains By Investing.com - Investing.com Australia
Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains - Investing.com India
Q1 2026 PAVmed Inc Earnings Call Transcript - GuruFocus
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call Transcript - Insider Monkey
PAVmed (NASDAQ: PAVM) Q1 2026 results, losses and cash position - Stock Titan
PAVmed Q1: cancer test and implantable monitor push toward coverage, FDA - Stock Titan
Canaccord Genuity Sticks to Its Buy Rating for Lucid Diagnostics (LUCD) - The Globe and Mail
Lucid says $44.8M pro forma cash extends runway well into 2027 as it awaits Medicare LCD - MSN
Lucid Diagnostics Inc.Common Stock (NQ: LUCD - FinancialContent
PAVmed Inc.Series Z Warrant (NQ: PAVMZ - FinancialContent
Lucid Diagnostics Earnings Call Balances Progress, Pressure - TipRanks
PAVmed Reports Business Expansion and Financial Update - Intellectia AI
PAVmed (NASDAQ: PAVM) posts Q1 2026 loss and flags going concern risks - Stock Titan
Lucid Diagnostics Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Lucid Diagnostics Releases Q1 2026 Financial Results - AlphaStreet
LUCD Q1 2026 Earnings Transcript - The Globe and Mail
Lucid Diagnostics Q1 Earnings Call Highlights - Yahoo Finance
LUCD: Q1 revenue reached $1.3M on 3,177 tests, with cash runway extended and Medicare approval pending - TradingView
Lucid Diagnostics Reports Q1 2026 Financial Results: $1.3M Revenue, Strong Cash Position, and Medicare Reimbursement Milestone Progress - Minichart
Earnings call transcript: Lucid Diagnostics Q1 2026: Revenue Miss Despite EPS Match - Investing.com
LUCD: Q1 2026 delivered strong test volume, improved cash, and progress toward Medicare and VA revenue - TradingView
Lucid Diagnostics earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Lucid Diagnostics Reports Q1 2026 Results and Outlook - TipRanks
LUCID DIAGNOSTICS ($LUCD) Releases Q1 2026 Earnings - Quiver Quantitative
Lucid Diagnostics (NASDAQ: LUCD) narrows loss and extends cash runway into 2027 - Stock Titan
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results - marketscreener.com
Lucid Diagnostics (LUCD) Q1 Loss Widening To US$23.6 Million Tests Bullish Growth Narrative - Sahm
Lucid Diagnostics 1Q 2026: Revenue $1.26M, EPS ($0.17) — 10-Q Summary - TradingView
LUCD: Q1 2026 saw higher revenue but continued losses, with future viability hinging on reimbursement and capital - TradingView
Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Lucid Diagnostics (NASDAQ: LUCD) grows Q1 revenue but flags going-concern risk - Stock Titan
TradingKey - TradingKey
Fat Pitch FinancialsLucid Diagnostics Inc.Common Stock (Nasdaq:LUCD) Stock Quote - FinancialContent
Lucid Diagnostics Inc. (LUCD) may report negative earnings: Know the trend ahead of next week's release - MSN
Lucid Diagnostics (NASDAQ:LUCD) Stock Rating Lowered by Wall Street Zen - MarketBeat
Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Lucid Diagnostics (LUCD) to Release Earnings on Thursday - MarketBeat
Lucid Diagnostics Inc (LUCD) 財務データ
収益
当期純利益
現金流量
EPS
Lucid Diagnostics Inc (LUCD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
Aug 20 '25 |
Buy |
1.02 |
100,000 |
101,840 |
665,443 |
1.27%
2.05%
大文字化:
|
ボリューム (24 時間):